Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MOdalities of Use, effectiveNEss and TOlerability of Eqwilate® a Balanced combInatiON of VWF and FVIII in Von WillEbrand Patients in Real-life Conditions: the ONE-TO-ONE Study

NCT04106908 is registered in ClinicalTrials.gov with Octapharma as lead sponsor.

NCT NCT04106908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04106908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MOdalities of Use, effectiveNEss and TOlerability of Eqwilate® a Balanced combInatiON of VWF and FVIII in Von WillEbrand Patients in Real-life Conditions: the ONE-TO-ONE Study
Lead sponsor
Octapharma
Phase
Observational
Overall status
Active, not recruiting
Start date
November 27, 2019
Completion date
November 30, 2026
Enrollment
38 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

vwd - von willebrand's disease